Non‐Covalent Organocascade Catalysis: Michael–Mannich Synergy for Enantioselective Building of <i>Aza</i>‐Spirocycles

Abstract The Michael–Mannich reaction has evolved into a cornerstone of synthetic organic chemistry, enabling the rapid and efficient building of architecturally complex molecular frameworks, particularly spirocyclic scaffolds. These distinctive structures, featuring rigid, fused‐ring systems, exhibit remarkable conformational properties and biological relevance, rendering them highly sought‐after motifs in pharmaceutical and natural product synthesis. Despite significant advances, the enantioselective construction of spiro‐quaternary centers remains a formidable challenge, demanding innovative catalytic strategies. Central to this pursuit is the activation of achiral substrates and precise stereocontrol, historically achieved through transition metal catalysis, biocatalysis, and organocatalysis. Among these, organocatalysis has redefined asymmetric synthesis by harnessing enantiomerically pure organic catalysts to mediate highly stereocontrolled transformations. Notably, non‐covalent organocatalysis—driven by finely tuned hydrogen bonding and other weak intermolecular forces—has emerged as a powerful platform to transcend the inherent limitations of metal‐ and enzyme‐based systems. This review spotlights recent breakthroughs in non‐covalent organocascade catalysis, emphasizing the strategic Michael–Mannich synergy for the enantioselective building of aza‐spirocycles. By emulating enzymatic activation and control mechanisms, researchers have unlocked unprecedented levels of enantio‐ and diastereoselectivity, charting transformative pathways for constructing architecturally complex, biologically potent spirocyclic molecules. This burgeoning approach not only expands the frontier of asymmetric catalysis but also sets the stage for next‐generation innovations in complex molecule synthesis.